LYTIR

Company · HUMA

Humacyte, Inc.

Nasdaq's symbol directory lists HUMA on Nasdaq as “Humacyte, Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 3 occasions ($30K); 4 filings by holders of 5% or more; 1 company report (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $30K in total; Insider sales: $0 in total.Aug: Insider purchases $25KSep: Insider purchases $6KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $30KInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Keith A. Jones bought on 3 days latest Sep 14, 2026 bought $30K
Every trade (3)
  1. BUYKeith A. Jones bought Sep 14, 2026 10,000 shares filing $6K
  2. BUYKeith A. Jones bought Aug 20, 2026 10,000 shares filing $7K
  3. BUYKeith A. Jones bought Aug 17, 2026 30,000 shares filing $18K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ filed Aug 18, 2026 Schedule 13D/A may seek influence 13,603,235 shares filing 4.9%
  2. FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ filed Jul 13, 2026 Schedule 13D/A may seek influence 18,312,735 shares filing 6.8%
  3. DAVIDSON KEMPNER CAPITAL MANAGEMENT LP filed Jun 22, 2026 Schedule 13G passive filing 0.09%
  4. FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ filed Jun 15, 2026 Schedule 13D/A may seek influence 18,312,735 shares filing 6.8%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Departure or appointment of directors or officers; Regulation FD disclosure filing Sep 28, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.